TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Dne Pharma AS
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
49,396
|
41,381
|
30,060 |
Financial expenses |
2,281
|
2,049
|
15,690 |
Earnings before taxes |
9,052
|
6,445
|
-13,396 |
Total assets |
96,718
|
77,591
|
73,431 |
Current assets |
43,413
|
34,790
|
19,167 |
Current liabilities |
31,330
|
20,734
|
24,870 |
Equity capital |
55,886
|
47,195
|
39,420 |
- share capital |
150
|
146
|
136 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
57.8%
|
60.8%
|
53.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
18.3%
|
15.6%
|
-44.6% |
Return on assets (ROA) |
11.7%
|
10.9%
|
3.1% |
Current ratio |
138.6%
|
167.8%
|
77.1% |
Return on equity (ROE) |
16.2%
|
13.7%
|
-34.0% |
Change turnover |
6,732
|
9,090
|
3,172 |
Change turnover % |
16%
|
28%
|
12% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.